Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,571.3
31.9 (1.26%)

 

  • STI Straits Times Index
    2,571.3
    31.9 (1.26%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,369.8
    8.4 (0.61%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,300.3
    330.0 (1.38%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,825.9
    10.5 (0.37%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    19,345.8
    -7.5 (-0.04%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,649.1
    22.4 (0.48%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,524.5M
  • Value: 1,408.7M
  • Rise: 279
  • Fall: 74
  • Unch: 459

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.120+0.010
ESR-REIT0.280+0.025
Genting Sing0.725-0.020
Lippo Malls Tr0.103-0.003
Broadway Ind^0.087+0.002
CapitaMall Trust1.680-0.020
Singtel2.710+0.100
AusGroup^0.025+0.001
OEL0.020+0.001
Golden Agri-Res0.164+0.008

World Indices

World Indices
Name Last Change
Nasdaq 8,090.9 +203.6
HSI 24,300.3 +330.0
HSCEI 9,811.1 +129.2
Jakarta 4,649.1 +22.4
Nikkei 225 19,345.8 -7.5
SSE Comp 2,825.9 +10.5
Shanghai A 2,961.5 +11.1
Shanghai B 219.7
KOSPI 1,836.2 +29.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

MORPHIC HOLDING INC MORPHIC HOLDING
Updated on 08 Apr 2020 (End of trading day)
Last (USD): 13.700 Change: +0.570 High: 13.765 Remarks: -
Change (%): +4.34 Low: 12.580
Open 13.170 Yesterday's Close 13.129999999999999
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 49,977 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.78175 Trailing EPS (USD) e -0.78175 NAV (USD) b 5.2273
PE a - Trailing PE f - Price / NAV b 2.6209
Dividend (USD) d - Cash In Hand (USD) g 5.2423 Issued & Paid-up Shares c 30,484,000
Dividend Yield (%) d - Price / Cash In Hand g 2.613 Treasury Shares h -
Beta - 75 Daysi 1.232 R-Squared - 75 Days(%)i 36.77 Market Cap (M) 417.631
Beta - 500 Daysi 1.135 R-Squared - 500 Days (%)i 16.18 Enterprise Value (M) 165.885
Piotroski F Score 3 Exchange Code MORF Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 40.3
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 13 Nov 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 19 Jun 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference MORPHIC HOLDING INC NASDAQ 417.631 - - 2.6209 -
Industry Biotechnology NASDAQ 2,369.808 271.312 257.900 5.6765 0.769
Local Peer AMGEN INC NASDAQ 129,279.796 15.401 16.486 13.3650 2.571
Local Peer GILEAD SCIENCES INC NASDAQ 94,413.160 17.308 17.529 4.1915 3.096
Local Peer VERTEX PHARMACEUTICAL NASDAQ 64,729.099 30.876 55.004 10.6370 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 56,366.531 23.059 26.641 5.0828 -
Local Peer BIOGEN INC NASDAQ 55,169.585 12.452 9.369 4.1347 -
Local Peer ILLUMINA INC NASDAQ 41,305.530 50.007 41.223 8.9541 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 21,890.176 282.092 9.105 1.9420 -
Local Peer SEATTLE GENETICS INC NASDAQ 20,616.077 - - 10.9877 -
Local Peer INCYTE CORPORATION NASDAQ 19,022.094 173.728 42.564 7.3207 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 14,322.110 - - 4.5869 -
Local Peer GALAPAGOS NV SPON ADR REPR 1 ORD SHS NASDAQ 13,138.811 - 42.334 4.7536 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 12,595.090 - - 8.7545 -
Other Local Peers MODERNA INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), IMMUNOMEDICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), ALKERMES PLC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), KODIAK SCIENCES INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ALECTOR INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), XENCOR INC (NASDAQ), INSMED INC (NASDAQ), VIELA BIO INC (NASDAQ), EPIZYME INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), VERACYTE INC (NASDAQ), REGENXBIO INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), TG THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), NEXTCURE INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), NOVAVAX INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), CYTOKINETICS INC (NASDAQ), OMEROS CORP (NASDAQ), PASSAGE BIO INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), RETROPHIN INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), COMPUGEN (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), IMMUNOGEN INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), AVROBIO INC (NASDAQ), ARDELYX INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), VERASTEM INC (NASDAQ), PRECIGEN INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), PROTHENA CORP PLC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), UROGEN PHARMA LTD (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), AGENUS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), NANTKWEST INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), KAMADA (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), MACROGENICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), AVID BIOSERVICES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), SERES THERAPEUTICS (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), GERON CORP (NASDAQ), ADURO BIOTECH INC (NASDAQ), XOMA CORP (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), RECRO PHARMA INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), VBI VACCINES INC CDA (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), IVERIC BIO INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), CABALETTA BIO INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), CHIASMA INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), AFFIMED N V (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), INFLARX N V (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), VAXART INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), SAVARA INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ARAVIVE INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), CHIMERIX INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), VERMILLION INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), CONTRAFECT CORP (NASDAQ), IMV INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), ORGENESIS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), VACCINEX INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), COHBAR INC (NASDAQ), OTONOMY INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), SESEN BIO INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), RESTORBIO INC (NASDAQ), ADVAXIS INC (NASDAQ), INMUNE BIO INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), SOLIGENIX INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ZAFGEN INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), EVOGENE LTD (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ATYR PHARMA INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), CURIS INC (NASDAQ), TOCAGEN INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), BIOCARDIA INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), OCUGEN INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), SENESTECH INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ)
Global Peer CSL ASX 149,382.121 55.679 51.568 17.2728 0.806
Global Peer AMGEN-T HKEx 589,807.000 8.965 9.598 7.8255 4.417
Global Peer AGILENT TECHNOLOGIES INC NYSE 23,747.135 75.149 31.083 4.8983 0.854
Global Peer WUXI BIO HKEx 147,548.970 197.547 128.542 10.3177 -
Global Peer SINO BIOPHARM HKEx 141,904.374 13.243 46.102 4.0775 0.648
Global Peer BEIGENE HKEx 84,959.680 - - 11.3321 -
Global Peer Lonza SGX 5,937.453 6.613 6.613 0.6568 4.787
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 3,220.360 51.361 58.981 2.9585 -
Global Peer GENSCRIPT BIO HKEx 24,356.521 146.476 - 8.1658 -
Global Peer 3SBIO HKEx 21,932.467 14.498 19.979 2.0371 -
Other Global Peers ALPHAMAB-B (HKEx), HAOHAI BIOTEC (HKEx), FRONTAGE (HKEx), VIVA BIOTECH (HKEx), POLYNOVO LIMITED (ASX), MYOVANT SCIENCES LTD (NYSE), ASCENTAGE-B (HKEx), ARCUS BIOSCIENCES INC (NYSE), AVITA MEDICAL LTD (ASX), KADMON HLDGS INC (NYSE), MESOBLAST LTD (ASX), SINOMAB BIO-B (HKEx), ASCLETIS-B (HKEx), NANOVIRICIDES INC (NYSE American), ESSEX BIO-TECH (HKEx), LEE'S PHARM (HKEx), BBI LIFE SCI (HKEx), DPHARMA (Bursa), PFENEX INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), TELIX PHARMACEUTIC (ASX), UNI-BIO GROUP (HKEx), NEXT SCIENCE LTD (ASX), ENZO BIOCHEM INC (NYSE), LINEAGE CELL THERAPEUTICS INC (NYSE American), CEL-SCI CORP (NYSE American), IBIO INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), PALATIN TECHNOLOGIES INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), IMUGENE LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), BIOTRON (ASX), CT ENTERPRISE (HKEx), SYNTHETIC BIOLOGICS INC (NYSE American), BIOSINO BIO-TEC (HKEx), INVEX THERAPEUTICS LTD NPV (ASX), IMMUTEP LTD (ASX), ORAGENICS INC (NYSE American), HOLISTA COLLTECH LIMITED (ASX), KAZIA THERAPEUTICS LIMITED (ASX), MEMPHASYS LTD (ASX), ANTEOTECH LIMITED (ASX), BIONOMICS LTD (ASX), REGENT PACIFIC (HKEx), ACTINIUM PHARMACEUTICALS INC (NYSE American), Suntar Eco-City^ (SGX), ACTINOGEN MEDICAL LTD (ASX), GENETIC TECHNOLOGIES (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), CCP TECHNOLOGIES LTD (ASX), HAO WEN HLDGS (HKEx), NOVABAY PHARMACEUTICALS INC (NYSE American), REGENEUS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), PATRYS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), RHINOMED LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), SIENNA CANCER DIAGNOSTICS LTD (ASX), BENITEC BIOPHARMA LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), ADALTA LTD (ASX), LEAF RESOURCES LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), NANOLLOSE LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), CRYOSITE (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.510
-3.59 %
10 Days -+0.220
+1.63 %
20 Days -+1.540
+12.66 %
Medium Term Return 3 Months --4.360
-24.14 %
6 Months --0.980
-6.68 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 9.900 - 33.500 Change From 1 Year Low +3.800 % Change From 1 Year Low (%) +38.38
Change From 1 Year High -19.800 % Change From 1 Year High (%) -59.10
2 Years Range 9.900 - 33.500 Change From 2 Years Low +3.800 % Change From 2 Years Low (%) +38.38
Change From 2 Years High -19.800 % Change From 2 Years High (%) -59.10
5 Years Range 9.900 - 33.500 Change From 5 Years Low +3.800 % Change From 5 Years Low (%) +38.38
Change From 5 Years High -19.800 % Change From 5 Years High (%) -59.10
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
08 Apr 2020 13.170 13.765 12.580 13.700 49,977 -
07 Apr 2020 15.320 15.770 12.620 13.130 38,588 -
06 Apr 2020 13.920 15.500 13.920 15.000 46,417 -
03 Apr 2020 13.900 14.020 12.480 13.610 56,506 -
02 Apr 2020 13.270 14.210 12.900 14.210 25,009 -
01 Apr 2020 14.380 14.590 13.130 13.610 41,757 -
31 Mar 2020 14.370 15.430 13.510 14.680 48,620 -
30 Mar 2020 14.120 15.435 13.570 14.620 111,337 -
27 Mar 2020 13.010 14.450 12.780 14.010 62,523 -
26 Mar 2020 13.130 13.680 12.810 13.480 109,604 -
25 Mar 2020 13.220 13.840 12.570 13.040 89,754 -
24 Mar 2020 12.730 13.650 12.730 13.300 89,616 -
23 Mar 2020 13.780 14.490 11.090 12.000 109,633 -
20 Mar 2020 14.110 15.250 12.990 13.420 934,298 -
19 Mar 2020 12.780 14.470 12.220 13.600 78,299 -
18 Mar 2020 11.700 13.570 10.100 12.410 104,028 -
17 Mar 2020 11.000 13.170 9.900 13.000 176,424 -
16 Mar 2020 11.440 12.350 10.320 10.840 139,334 -
13 Mar 2020 12.630 12.830 11.010 12.770 71,433 -
12 Mar 2020 13.620 14.830 11.970 12.160 48,260 -
11 Mar 2020 14.930 15.310 14.150 14.410 83,431 -
10 Mar 2020 14.330 16.130 14.330 15.410 114,336 -
Summary
Current 2 Weeks
(26 Mar 2020 to 08 Apr 2020)
13.130 15.770 12.480 13.700 590,338 -
Previous 2 Weeks
(12 Mar 2020 to 25 Mar 2020)
13.620 15.770 11.970 13.040 1,841,079 -
4 Weeks from
(12 Feb 2020 to 11 Mar 2020)
17.830 18.485 12.480 14.410 2,609,554 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.